CD93 and myelodysplastic syndrome: Changes in the size of MDS-specific clusters were observed between low and high-risk samples and genes previously associated with AML such as ID1, CD93 and CALCRL were activated by cells within these clusters together with genes coding for several insulin-growth factor binding proteins (IGFBP).